                         SEQUENCE LISTING

<110>  GE Healthcare UK Limited
 
<120>  Methods and Reagents for Reverse -Transcription Polymerase Chain 
       Reaction

<130>  277644-2

<140>  PCT/US 15/066576
<141>  2015-12-18

<150>  GB 1423076.7
<151>  2014-12-23

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  1
ggtgaacgtg gatgaagttg                                                   20


<210>  2
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  2
agcacacaga ccagcacgt                                                    19


<210>  3
<211>  18
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  3
cctcgccttt gccgatcc                                                     18


<210>  4
<211>  23
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  4
ggatcttcat gaggtagtca gtc                                               23


<210>  5
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  5
agaaggctgg ggctcatttg                                                   20


<210>  6
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  6
aggggccatc cacagtcttc                                                   20


